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Abstract
Purpose:To determine the incidence of exercise-associated hyponatremia (EAH), the associated biochemical
measurements and risk factors for EAH, and whether there is an association between postrace blood sodium
concentration ([Na+]) and changes in body mass among participants in the 2009 Western States Endurance
Run, a 161-km mountain trail run.
Methods: Change in body mass, postrace [Na+], and blood creatine phosphokinase (CPK) concentration, and
selected runner characteristics were evaluated among consenting competitors.
Results: Of the 47 study participants, 14 (30%) had EAH as defined by a postrace [Na+] /L. Postrace [Na+]
and percent change in body mass were directly related (r = .30, P = .044), and 50% of those with EAH had
body mass losses of 3–6%. EAH was unrelated to age, sex, finish time, or use of nonsteroidal anti-
inflammatory drugs during the run, but those with EAH had completed a smaller (P = .03) number of
161-km ultramarathons. The relationship of CPK levels to postrace [Na+] did not reach statistical significance
(r = –.25, P = .097).
Conclusions: EAH was common (30%) among finishers of this 161-km ultramarathon and it was not unusual
for those with EAH to be dehydrated. As such, changes in body mass should not be relied upon in the
assessment for EAH during 161-km ultramarathons.
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Purpose: To determine the incidence of exercise-associated hyponatremia (EAH), the associated biochemical 
measurements and risk factors for EAH, and whether there is an association between postrace blood sodium 
concentration ([Na+]) and changes in body mass among participants in the 2009 Western States Endurance 
Run, a 161-km mountain trail run. Methods: Change in body mass, postrace [Na+], and blood creatine phos-
phokinase (CPK) concentration, and selected runner characteristics were evaluated among consenting competi-
tors. Results: Of the 47 study participants, 14 (30%) had EAH as defined by a postrace [Na+] <135 mmol/L. 
Postrace [Na+] and percent change in body mass were directly related (r = .30, P = .044), and 50% of those 
with EAH had body mass losses of 3–6%. EAH was unrelated to age, sex, finish time, or use of nonsteroidal 
anti-inflammatory drugs during the run, but those with EAH had completed a smaller (P = .03) number of 
161-km ultramarathons. The relationship of CPK levels to postrace [Na+] did not reach statistical significance 
(r = –.25, P = .097). Conclusions: EAH was common (30%) among finishers of this 161-km ultramarathon 
and it was not unusual for those with EAH to be dehydrated. As such, changes in body mass should not be 
relied upon in the assessment for EAH during 161-km ultramarathons.
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The development of exercise-associated hyponatre-
mia (EAH; blood sodium concentration of <135 mmol/L) 
appeared to be an unusual consequence of endurance 
exercise when first described in non-peer-reviewed maga-
zines in the early 1980s1,2 and the scientific literature in 
1985.3 Since these initial descriptions, at least nine deaths 
from EAH have been confirmed and this potentially fatal 
medical condition has been found to be common in a 
variety of endurance activities.4 For instance, the inci-
dence of EAH has been observed to be as high as 18% 
in Ironman triathlons,5 13% in standard marathons (42 
km),6,7 and 12% in an endurance cycling event,8 but as 
low as 0–0.6% in other ultraendurance events.9–11
In our recent work, we saw an alarmingly high EAH 
incidence of 51% during a 161-km trail ultramarathon 
that was run under hot conditions.12 That study also noted 
that 57% (12 of 21) of the hyponatremic finishers had lost 
>3% of their body mass. This was in contrast to previous 
studies, mostly from shorter duration competitions, in 
which EAH was relatively rare in subjects who had lost 
that much body mass.6,13–16 Further work to clarify the 
incidence of hyponatremia with such levels of weight 
loss is of critical importance because runners presenting 
for medical attention with >3% body mass loss would 
typically be treated with aggressive rehydration. Such 
treatment in the presence of hyponatremia could be fatal.
The present study examined the incidence of hypo-
natremia in a 161-km ultramarathon run to determine if 
the high incidence of EAH we previously observed in 
such an event12 would be replicated. We also wished to 
determine whether change in body mass was related to 
EAH occurrence, and whether EAH would again prove to 
be common among those with weight loss.12 Finally, we 
sought to discover whether select runner characteristics 
were related to the development of EAH. Since previ-
ously reported risk factors for EAH have included female 
sex, slow performance, event inexperience, and use of 
nonsteroidal anti-inflammatory drugs (NSAIDs) during 
the event,17 we examined these variables. Because there 
has been suggestion of an association between EAH and 
rhabdomyolysis,18–21 we also examined postrace blood 
creatine phosphokinase (CPK) concentrations.
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Methods
The study was performed at the 2009 Western States 
100-Mile (161-km) Endurance Run (WSER), in Northern 
California. The course is almost entirely on single track 
mountain trails with 5500 m of cumulative climb and 
7000 m of cumulative descent. Twenty-four aid stations 
were stocked with various fluids, nutritional items, and 
salt capsules. Body mass was measured at nine of these 
stations during the race, and race policy was to force 
rest and rehydration for competitors whose body mass 
loss was >5% compared with their registration mass. 
Participants had 30 h to complete the race. Nearby ambi-
ent temperature ranged from 4°C to 37°C.
Institutional Review Board approval was granted 
for this study and subjects provided informed consent. 
Subjects were recruited via prerace emails and during 
race registration the day before the race. Body mass 
was measured with a weight scale (WW42D impedance 
scale, Weight Watchers, New York City, NY) positioned 
on a solid level surface during race registration with 
the subjects barefoot and wearing lightweight running 
clothes. Within a few minutes of finishing the race, 
barefoot body mass was measured with the same scale 
on a solid level surface, and blood was drawn from an 
antecubital vein for onsite analysis of sodium concentra-
tion ([Na+]) using an I-Stat portable analyzer (Abbott, 
Princeton, NJ). The I-Stat has been reported to have a 
coefficient of variation of ≤0.01% in the measurement 
of [Na+] and to yield a strong correlation (r = .95) with 
the Ciba Corning 288 blood gas analyzer for [Na+].22 
Blood was also sent to the local hospital laboratory for 
determination of blood CPK concentration. Creatine 
phosphokinase values over 40,000 U/L were not diluted 
for further analysis and were reported as >40,000.
Each subject was sent an e-mail the day following 
the race with an invitation to complete an electronic 
survey. Details of the methods and findings of the survey 
are provided elsewhere.23,24 Select questions used in the 
present study were those determining whether nausea 
had affected race performance, if NSAIDs were used 
during the race, the greatest distance run in one week 
during the 3 mo before the race, and the number of 
prior 161-km running races completed. The latter was 
determined from our records25,26 for those runners not 
completing the postrace survey. Finish times and subject 
ages were obtained from official race results.
Unpaired t tests and Fisher’s exact tests were used 
to compare hyponatremic and normonatremic runners in 
interval and categorical variables, respectively. A non-
parametric Mann-Whitney test was used to analyze the 
number of previously completed 161-km races because 
these data were not normally distributed. Pearson cor-
relation analyses were used to examine the associations 
between interval variables after verifying the values 
approximated Gaussian distributions. A value of 40,000 
was used in the analyses for CPK values >40,000. Sta-
tistical significance was set at P < .05.
Results
A total of 104 of the 399 race starters consented to par-
ticipate in the study. Of those, 47 finished the race and 
provided blood samples upon completing the race, and 
14 (30%) of this group had a [Na+] below 135 mmol/L. 
All were fully oriented and without evidence of altered 
mental status.
Table 1 compares characteristics of normonatremic 
and hyponatremic groups. The two groups were not 
statistically different with regard to age, sex, finish time, 
highest training distance week, presence of nausea during 
the race, and use of NSAIDs during the race. Those who 
were normonatremic had a greater (P = .03) number of 
previous 161-km race finishes. Normonatremics also 
had trends (P = .06) toward less weight loss and lower 
postrace CPK concentrations than hyponatremic runners.
Table 1 Comparison of normonatremic and hyponatremic groups. Data are presented as mean ± 
SD except where indicated. The last three items are based upon survey responses from 35 of the 
47 study participants.
Item Normonatremic Hyponatremic P value
Postrace [Na+] (mmol/L) 138.3 ± 2.4 131.5 ± 2.2 <0.0001
Age (years) 44.6 ± 7.0 42.0 ± 9.6 0.30
Women (%) 18.2 28.6 0.46
Finish Time (hours) 25.84 ± 2.73 26.29 ± 2.80 0.61
Change (postrace minus registration) in Body Mass (%) –1.0 ± 2.6 –2.6 ± 2.5 0.06
Postrace CPK (U/L) 19,018 ± 13,467 27,518 ± 13,571 0.06
161-km Races Previously Completed (Median and Range) 3 (range 0–56) 1 (range 0–43) 0.03
Highest Running Distance in 1 Week (km) 139 ± 39 134 ± 44 0.73
Presence of Nausea (%) 43.5 58.3 0.49
Use of NSAIDs (%) 56.5 58.3 1.00
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Postrace [Na+] was positively and significantly 
related to percent change in body mass (Figure 1). Also 
notably evident from this figure is that 7 of the 14 hypo-
natremic runners lost 3–6% of body mass.
Finish time was unrelated to percent change in body 
mass (Figure 2). The greatest decrease in body mass 
(6.3%) was seen for the fastest study participant.
Creatine phosphokinase concentrations were unre-
lated to percent change in body mass (r = .08, P = .60) 
or to postrace [Na+] (Figure 3).
Discussion
The most important findings of this study are that 
there was a direct relationship between postrace [Na+] 
and percent change in body mass, and that half of the 
hyponatremic runners had lost >3% body mass during 
the race. These findings contrast with previous studies 
in which postrace [Na+] has universally been found to 
be inversely related to change in body mass.6,9,13–16,27 
Furthermore, a compilation of data from 2,135 finishes 
of different endurance events that were mostly shorter in 
duration than that of the present study demonstrated that 
the incidence of EAH was only 4% among those who lost 
>3% body mass.15 This contrasts with the present study in 
which EAH was present among 54% of those with >3% 
body mass loss. Yet, the current findings are consistent 
with those of Lebus et al12 and confirm that EAH can be 
relatively common during a 161-km ultramarathon when 
body mass loss is >3%. Furthermore, even if we were to 
consider a mass loss of 4% as the minimum required for 
dehydration, which would be appropriate based upon 
our energy balance data from this event,28 we would 
conclude that 50% (5 of 10) of the runners with such 
mass loss had EAH.
Another important finding of the present study was 
the high incidence of EAH. The 30% incidence of EAH 
in the present study was considerably higher than the 7% 
incidence in the compilation study.15 Furthermore, a com-
parable study of 13 finishers of a hot (21–38°C) 160-km 
ultramarathon run reported that none were hyponatremic 
at the finish.9 Yet interestingly, our current findings are 
consistent with the high incidence (51%) reported by 
Lebus et al12 during a 161-km ultramarathon, which, like 
the ultramarathon of the present study, took place under 
hot conditions in northern California on a challenging 
trail course. The reason for the apparently unique findings 
from these 161-km ultramarathons in northern California 
is not clear and invites further exploration.
Overhydration from excessive fluid intake is consid-
ered to be an important etiology of EAH.15,17 Considering 
overhydration as a lack of mass loss,15 34% of the present 
sample was found to be overhydrated. Yet, of those who 
overhydrated, only two (13%) developed biochemical 
EAH, and none developed clinically significant EAH. 
This differs considerably from the compilation study in 
which overhydration was present among only 11% of 
subjects, of which 11% and 19% developed biochemical 
EAH and clinically significant EAH respectively, for a 
total of 30% of those who were overhydrated developing 
Figure 3 — Relationships of CPK to postrace [Na+].
Figure 1 — Relationship of postrace [Na+] to percent change 
(postrace minus registration) in body mass.
Figure 2 — Relationships of finish time to percent change 
(postrace minus registration) in body mass.
EAH. Furthermore, 45% of those with EAH were over-
hydrated in the compilation study, whereas only 14% of 
those with EAH were overhydrated in the present study. 
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Thus, overhydration was more common in the present 
study, yet was not as likely to be associated with EAH as 
in the compilation study.
The high incidence of an increase in body mass in the 
present event probably relates to the emphasis on avoid-
ance of significant mass loss. Race policy at the time of 
the event required that runners be stopped and rehydrated 
for mass loss of >5%. The high incidence of an increase 
in body mass may also relate to a great emphasis in the 
United States on the use of sodium supplementation during 
endurance competitions. In fact, the WSER Participant’s 
Guide recommends sodium intake, and sodium capsules 
were provided at aid stations. Excessive sodium intake is 
likely to result in plasma volume expansion and gain in 
body mass.12,29 But, it is interesting that overhydration was 
less likely to be associated with EAH in this study com-
pared with others. The fact that most of the runners in the 
overhydrated group were normonatremic is consistent with 
the premise that excessive fluid intake was accompanied 
by aggressive sodium intake.
Previous work has concluded that sodium supplemen-
tation via salt capsules is unnecessary to maintain [Na+] 
during prolonged endurance exercise.14,29 However, the 
high incidence of EAH in 161-km ultramarathons observed 
in the present study and that of Lebus and colleagues,12 
along with the finding that EAH can commonly be associ-
ated with dehydration suggests that sodium loss may be 
an etiological factor in the development of EAH during 
these longer duration events under high ambient tempera-
tures. Alternatively, the osmotic inactivation of circulating 
sodium or failure to adequately mobilize osmotically inac-
tive sodium from internal stores have been suggested as 
underlying etiologies of EAH.15 Further work is required to 
fully illuminate the relative role of these potential mecha-
nism in EAH under the conditions of this event.
The present study examined other risk factors for 
EAH. Previously reported risk factors for EAH include 
female sex, slow performance, event inexperience, and 
use of NSAIDs during the event.17 The present work found 
no statistical evidence for EAH being related to age, sex, 
race performance, or use of NSAIDs. However, this work 
does support higher risk associated with fewer previous 
event completions.
Nonosmotic secretion of arginine vasopressin is felt to 
be an exacerbating factor in most cases of EAH.17 Nausea 
is a potential nonosmotic stimulus for arginine vasopressin 
secretion. While about half the subjects reported nausea, 
there was no difference in the frequency of nausea between 
those who presented with EAH and those who did not.
Recent case reports have suggested a link between 
rhabdomyolysis and EAH.18–21 Theoretically, EAH could 
promote rhabdomyolysis through changes in intracellular 
potassium or calcium concentrations, or through hypotonic 
extracellular fluid being drawn into the muscle cell, each of 
which could reduce the stability of the cell membrane and 
allow for easier breakdown. Conversely, the breakdown of 
muscle cells could lead to third spacing of fluids, which 
could stimulate arginine vasopressin secretion leading 
to EAH. The present study examined CPK levels, and 
although statistical differences between hyponatremic 
and normonatremic groups were not found (P = .06), the 
data suggest that closer examination with a larger subject 
sample is warranted.
This study examined only postrace [Na+] rather than 
prerace to postrace change in [Na+], as has been the case 
for some studies.9,27,30 We believe that postrace [Na+] is 
the more relevant measure and likely to be more reflec-
tive of any change in [Na+] from normal baseline under 
the conditions of this study. The WSER weighing policy 
has engendered a culture in which runners try to weigh-
in light at registration. They typically weigh-in in the 
morning before eating on the day before the race so that 
the value is lower than it would be the next morning after 
aggressively hydrating during the remaining hours before 
the race. This practice may cause a transient lowering of 
prerace [Na+] that would not accurately reflect the normal 
baseline value for these individuals. For the same reason, 
we believe that our use of body mass measurements at 
registration the day before the event is more reflective of 
a normal baseline than measurements made immediately 
prerace. Previous work has demonstrated that body mass 
immediately before the start of an endurance competition 
is 0.6–1.05 kg higher than at race registration11,31–33 sup-
porting the premise that such measurements may reflect 
an overhydrated state rather than a normal baseline. As 
such, our use of body mass measurements from registration 
would tend to underestimate mass loss during the event 
relative to what would be determined based upon prerace 
measurements. This means that the proportion of runners 
with EAH who had >3% mass loss would likely have been 
even higher than 50% had we used body mass measure-
ments from immediately before the race. Regardless, the 
reality is that the registration weight is the value used by 
race officials, and so this value has the greatest practical 
importance in this race.
The lowest postrace [Na+] we observed was 126 
mmol/L. In fact, only this one case was in the “clinically 
significant” range (<128.9 mmol/L) as defined by Noakes 
et al.15 Furthermore, none of our cases displayed evidence 
of hyponatremic encephalopathy. Yet, asymptomatic EAH 
can rapidly progress to severe illness.17 Thus, further inves-
tigation into the underlying mechanism and the explanation 
for the high incidence of EAH in 161-km ultramarathons 
is warranted.
The high incidence of EAH we have observed during 
hot weather 161-km ultramarathons makes it imperative 
that on-site and local emergency medical personnel be 
cognizant that some runners seeking medical attention 
are likely to be hyponatremic. In addition, EAH can occur 
with considerable loss in body mass during a hot 161-km 
ultramarathon indicating that changes in body mass cannot 
be relied upon in the clinical assessment for EAH. As such, 
the need for onsite [Na+] analysis, as recommended by the 
EAH Consensus Group,17 is justified. Furthermore, encour-
agement of oral hypotonic fluids or the administration of 
intravenous hypotonic fluids, even in athletes who present 
as fluid depleted, is risky without knowing the [Na+].
In summary, this work demonstrates that EAH can be 
common (30% incidence) among finishers at a hot 161-km 
run and that it may not be unusual for those with EAH to 
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be dehydrated. The development of EAH was unrelated 
to age, sex, finish time, or use of NSAIDs during the run, 
but those developing EAH had completed fewer 161-km 
ultramarathons.
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